FOXM1 and breast cancer: Interestingly, the expression of FOXM1 correlated with reduced RFS of breast cancer patients regardless of their nodal status and tumor grade (except for Grade III) (LN-positive: HR = 1.74, P = 3.9e-08; LN-negative: HR = 1.7, P = 9.1e-10; Grade I: HR = 3.31, P = 3.7e-05; Grade II: HR = 1.55, P = 0.00034) (Table 2).